Patients with congestive cardiomyopathy as cardiac transplant recipients. Indications for and results of cardiac transplantation and comparison with patients with coronary artery disease.
Patients with congestive cardiomyopathy as cardiac transplant recipients. Indications for and results of cardiac transplantation and comparison with patients with coronary artery disease.
复制标题
作为心脏移植受者的充血性心肌病患者。
DOI：
10.1016/0002-9149(81)90248-4
复制
发表时间：
1981
期刊：
影响因子：
--
通讯作者：
Stinson,EB
中科院分区：
文献类型：
--
作者：
Hassell,LA;Fowles,RE;Stinson,EB
In recent years end-stage congestive cardiomyopathy has become an increasingly frequent clinical diagnosis in candidates for cardiac transplantation. Forty-six patients who underwent transplantation because of congestive cardiomyopathy and 59 because of coronary artery disease were studied between 1971 and 1978 at Stanford University. The overall 1 year survival rate was similar in the two groups: cardiomyopathy-transplant, 64 percent and coronary artery disease-transplant, 55 percent. The survival rate has improved substantially for both groups within the last decade: The 3 year survival rate for cardiomyopathy-transplant patients undergoing cardiac transplantation since 1974 is nearly 60 percent. In contrast, 36 similarly ill patients with cardiomyopathy not undergoing transplantation had a 1 year survival rate of 23 percent and a 3 year survival rate of 4 percent (p <0.001). Survival rates in the cardlomyopathy-transplant group were unaffected by age (greater or less than 40 years). Patients in this group under age 40 had a lower frequency of infection (1 per 313 patient-days versus 1 per 195 patient-days in the older group, p <0.05) and a significantly longer interval to second rejection episodes (p <0.05), a measure of rejection frequency. Cardiomyopathy-transplant patients under age 40 had fewer deaths due to rejection (17 percent) compared with older patients in this group (36 percent). Cardiac transplantation is an effective treatment for end-stage congestive cardiomyopathy.
登录
查看更多内容
DOI：
10.1016/s0140-6736(77)91514-8
发表时间：
1977-08
期刊：
The Lancet
影响因子：
--
作者：
A. Musca;C. Cordova;F. Violi
通讯作者：
A. Musca;C. Cordova;F. Violi
DOI：
--
发表时间：
1973
期刊：
Recent advances in studies on cardiac structure and metabolism
影响因子：
--
作者：
Barnard Cn
通讯作者：
Barnard Cn
影响因子：
0.9
作者：
J. Schroeder;A. Rider;Stinson Eb;Shumway Ne
通讯作者：
Shumway Ne
特发性心肌病、年龄和抑制细胞功能障碍是心脏移植后淋巴瘤的风险决定因素
DOI：
--
发表时间：
1978
期刊：
The Lancet
影响因子：
--
作者：
Jeffrey L. Anderson;C. Bieber;R. Fowles;E. Stinson
通讯作者：
E. Stinson
同意的医学证据。
DOI：
--
发表时间：
1962
期刊：
The Lancet
影响因子：
--
作者：
N. Primost
通讯作者：
N. Primost